abstract |
The present invention provides transgenic non-human animals associated with isoQC-related diseases, particularly transgenic mice encoding isoQC. The present invention further provides cells and cell lines comprising a transgene encoding isoQC. The present invention further provides methods and compositions for assessing agents that affect isoQC for use in compositions for the treatment of isoQC related diseases. [Selection figure] None |